RBC Capital buyers of Addus HomeCare shares amid weakness

RBC Capital notes Addus HomeCare (ADUS) shares traded down almost 11% intraday after the company posted what the firm calls “solid” Q4 results and provided “extensive commentary” on the company’s Medicaid policy exposure. Addus has “minimal” Medicaid policy exposure and boasts a strong revenue growth outlook, bolstered by recent M&A, argues the firm, which would be buyers on weakness. RBC has an Outperform rating and $136 price target on the shares.